The subsequent investigated the use of TXA for preventing PPH in women with moderate to severe anaemia. Unlike the original trial's treatment results, WOMAN-2 found that while anaemic women were at much higher risk for PPH, prophylactic TXA did not significantly reduce that risk in this specific population.
If your query regarding "Woman Trial TXA" referred to suffering from heavy menstrual bleeding (HMB), the relevant trials are distinct from the "WOMAN Trial" described above. woman trial txa